Akèy › Limfom Selil-T › Connecticut › New Haven
Etid klinik pou Limfom Selil-T nan New Haven, CT
5 etid pou Limfom Selil-T ap chèche patisipan nan sit nan ak bò kote New Haven (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
Ap rekriteFaz 3
- Yale University, New Haven
A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL
Ap rekriteFaz 2
- Yale Cancer Center, New Haven
Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma
Ap rekriteFaz 2
- Yale Smilow Cancer Hospital, New Haven
A Registry for People With T-cell Lymphoma
Ap rekriteEtid obsèvasyon
- Yale University (Data Collection Only), New Haven
Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma
Ap rekriteFaz 2
- Yale Cancer Center, Clinical Trials Office, New Haven
Etid Limfom Selil-T nan lòt vil
- New York City, NY13 etid
- Philadelphia, PA10 etid
- Baldwin Park, CA9 etid
- Boston, MA9 etid
- Houston, TX8 etid
- Atlanta, GA8 etid
- Chicago, IL6 etid
- Seattle, WA6 etid
- Columbus, OH6 etid
- Rochester, MN6 etid
- Miami, FL5 etid
- Ann Arbor, MI4 etid
Lòt etid nan New Haven
- Kansè Poumon ki pa ti selil41 etid
- Kansè nan tete37 etid
- Kansè (tout kalite)33 etid
- Kansè Metastatik23 etid
- Kansè poumon22 etid
- Karsinòm selil skuamèz tèt ak kou22 etid
- Kansè ovè21 etid
- Kansè kolorektal20 etid
- Kansè pwostat20 etid
- Sòvdòz Opioyid18 etid
- Twoub Konsomasyon Alkòl (AUD)17 etid
- Leksemi mieloïd egi17 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.